Crohn's Disease		Infliximab
Crohn's disease; Crohn//'s disease; Inflamatory Bowel Disease; Inflammatory Bowel Disease, Crohn's		Remicade

Pictures

Schering Remicade s jpg

Infliximab REMICADE® is an anti inflammatory monoclonal antibody for the treatment of Crohn s disease and rheumatoid arthritis which is licensed from Centocor

---

Schering Remicade jpg

---

where is crohns disease jpeg

which include chronic diarrhea crampy abdominal pain loss of appetite and weight loss often mimic those of the other IBD type ulcerative colitis which affects only the colon Both illnesses are chronic says David S Kaminstein M D former chief of gastroenterology at The Chester County Hospital in West Chester Pa But Crohn s disease often leads to

---

Humira adalimumab better chioce for the treatment of crohns disease who were intolerant to Remicade infliximab jpg

Humira adalimumab better choice for the treatment of crohn s disease who were intolerant to Remicade infliximab Crohn s is a chronic inflammatory disease The other inflammatory bowel disease is ulcerative colitis of the gastrointestinal tract usually the small intestine It affects about 500 000

---

slide24 gif

treatment with this drug of virtually treating all the patients whether or not they have fistula with the 0 2 6 regimen to enhance their initial response and improve tolerance to the drug Slide Fistulizing Crohn s Disease Conclusions Infliximab has been rapidly effective for the treatment of CD and the ACCENT II trial will be to identify again the inductive regimen with 3

---

8 1941 4 jpg

with infliximab and were fatal in some cases Clinicians should determine if the benefits outweigh the risks prior to initiating infliximab treatment for Crohn s disease Antibodies known as human antichimeric antibodies HACA may develop in patients treated with infliximab This often leads to delayed hypersensitivity reactions and a loss in

---

slide16 gif

Slide Infliximab Treatment of Fistulae in Crohn s Disease The next study was done by Present and company And this was looking at fistulas disease And the endpoint the primary endpoint of

---

diagram gif

a protein that may serve as a pattern recognition receptor for bacterial lipopolysaccarides possibly regulating NF kB Hugot Chamaillard et al 2001 Ogura Bonen et al 2001 Therapeutic Options for Ulcerative Colitis and Crohn s Disease

---

slide25 gif

Slide Steroid Withdrawal in Luminal Crohn s Disease Infliximab Efficacy If we look at the University of Chicago experience Cohen presented this data about a year ago They looked at

---

slide26 gif

Slide Steroid Withdrawal in Luminal Crohn s Disease Infliximab Efficacy And this just shows you the steroid withdrawal the dose the daily dose as it occurs after each individual infusion

---

slide21 gif

Slide Background Slide Infliximab Therapy in Fistulizing CD Perianal CD has been examined in the study by Present where a series of 3 infusions at 0 2 and 6 weeks was administered Slide Clinical

---

slide20 gif

Slide Background Slide Infliximab Therapy in Fistulizing CD Perianal CD has been examined in the study by Present where a series of 3 infusions at 0 2 and 6 weeks was administered

---

slide22 gif

Slide Infliximab Therapy in Fistulizing CD Perianal CD has been examined in the study by Present where a series of 3 infusions at 0 2 and 6 weeks was administered Slide Clinical Response >50 Reduction in Open Fistulas Overall the benefits as far as greater than a 50 reduction in draining fistulas were seen in approximately 60 of patients treated

---

slide23 gif

the benefits as far as greater than a 50 reduction in draining fistulas were seen in approximately 60 of patients treated with infliximab compared to 20 of the patients with placebo Slide Rapid Achievement of Complete Closure of All Fistula s But an important aspect was that it did not require 3 infusions in order to obtain these clinical benefits We can see clinical

---

slide37 gif

that were accumulated for this study patients who were failing their current therapy or steroid dependent were treated with infliximab Slide Changes in Disease Activity With Infliximab Slide Steroid Sparing With Infliximab You can see a very rapid improvement in their clinical disease activity measured by the Pediatric Crohn s Disease Activity Index PCDAI within the first

---

section image jpg

Intestinal Dysbiosis Immunobilan Test Test Code IM01 The Immunobilan test is an antibody screening assay for IgA and IgM which recognize the surface proteins of

---

8 1941 2 jpg

---

8 1941 0 jpg

---

00e6 png

The insulin like growth factor IGF system and its relation to infliximab treatment in adult patients with Crohn s disease Authors Martin Eivindson a Henning Gr nb k a Kristin Skogstrand bc Poul Thorsen c Jan Frystyk d Allan Flyvbjerg d Jens F Dahlerup a

---

art ajhp5804 02 fig1 gif

---